Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin

@inproceedings{Onose2009NeuroprotectiveAC,
  title={Neuroprotective and consequent neurorehabilitative clinical outcomes, in 
patients treated with the pleiotropic drug cerebrolysin},
  author={Gh Onose and D Mureşanu and A. V. Ciurea and C O Chendreanu and A Mihăescu and D M Mardare and Ioana Andone and Aura Spanu and Cr Popescu and Anca Madalina Dumitrescu and M Popescu and V Grigorean and B Ungur and Florentina Marinescu and I Colibaşeanu and Liliana Valentina Onose and Monica Haras and A Sandu and Tiberiu Spircu},
  booktitle={Journal of medicine and life},
  year={2009}
}
BACKGROUND Discovery of neurotrophic factors--emblematic: the nerve growth factor (NGF)--resulted in better approaching central nervous system (CNS) lesions. Recently, another crucial property has been unveiled: their rather unique pleiotropic effect. Cerebrolysin is a peptide mixture that penetrates the blood-brain barrier in significant amounts and mimics the effects of NGF. METHODS Comparative analysis: Cerebrolysin treated (10 ml x 2/day, i.v. x 3 weeks) vs. non-treated, in patients (all… CONTINUE READING